TSE:CRON - Cronos Group Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$9.57
  • Forecasted Upside: -10.09 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.14 (1.33%)

This chart shows the closing price for CRON by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cronos Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRON and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRON

Analyst Price Target is C$9.57
▼ -10.09% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for Cronos Group in the last 3 months. The average price target is C$9.57, with a high forecast of C$13.00 and a low forecast of C$5.90. The average price target represents a -10.09% upside from the last price of C$10.64.

This chart shows the closing price for CRON for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Cronos Group. This rating has held steady since March 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/15/2021Raymond JamesReiterated RatingOutperformC$13.00
6/7/2021Raymond JamesReiterated RatingOUTPERFORMC$13.00
5/11/2021CowenLower Price TargetMarket PerformC$14.00 ➝ C$9.00
5/11/2021MKM PartnersBoost Price TargetBuyC$11.00 ➝ C$12.00
5/10/2021Raymond JamesBoost Price TargetOutperformC$13.00
5/10/2021Stifel NicolausLower Price TargetC$12.00 ➝ C$7.50
4/9/2021Jefferies Financial GroupBoost Price TargetOutperformC$5.00 ➝ C$5.90
3/3/2021Raymond JamesBoost Price TargetOutperformC$11.00
3/2/2021Pi FinancialBoost Price TargetNeutralC$7.50 ➝ C$10.00
3/1/2021CowenBoost Price TargetC$8.00 ➝ C$14.00
11/16/2020Jefferies Financial GroupLower Price TargetC$5.60 ➝ C$5.00
11/9/2020Pi FinancialLower Price TargetNeutralC$8.50 ➝ C$7.50
8/10/2020Jefferies Financial GroupLower Price TargetC$6.00 ➝ C$5.60
8/7/2020Pi FinancialSet Price TargetNeutralC$8.50
5/12/2020Jefferies Financial GroupLower Price TargetC$7.00 ➝ C$6.00
5/11/2020Stifel NicolausLower Price TargetC$8.00 ➝ C$7.50
5/11/2020Pi FinancialLower Price TargetNeutralC$9.00 ➝ C$8.50
4/7/2020CowenLower Price TargetC$10.00 ➝ C$8.00
4/1/2020Pi FinancialDowngradeBuy ➝ NeutralC$17.00 ➝ C$9.00
3/31/2020Raymond JamesLower Price TargetOutperformC$12.00 ➝ C$10.50
3/31/2020Canaccord GenuityDowngradeHold ➝ SellC$12.00 ➝ C$7.00
3/4/2020Raymond JamesSet Price TargetOutperformC$12.00
3/4/2020MKM PartnersLower Price TargetBuyC$12.00 ➝ C$11.00
3/3/2020Stifel NicolausDowngradeBuy ➝ HoldC$12.00 ➝ C$8.00
2/21/2020Pi FinancialReiterated RatingBuyC$17.00
2/10/2020Raymond JamesSet Price TargetOutperformC$12.00
1/2/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$7.00
12/20/2019Raymond JamesReiterated RatingOutperformC$12.00
11/13/2019Canaccord GenuityLower Price TargetC$13.00 ➝ C$12.00
11/13/2019CIBCLower Price TargetC$20.00 ➝ C$17.00
10/11/2019Jefferies Financial GroupLower Price TargetC$15.00 ➝ C$10.00
10/4/2019CIBCLower Price TargetC$25.00 ➝ C$20.00
9/5/2019BMO Capital MarketsUpgradeUnderperform ➝ Market PerformC$16.00
9/3/2019CowenLower Price TargetC$21.00 ➝ C$17.00
8/9/2019Canaccord GenuityUpgradeSell ➝ HoldC$16.00 ➝ C$17.00
6/5/2019Bank of AmericaUpgradeUnderperform ➝ BuyC$17.00 ➝ C$27.00
5/10/2019Canaccord GenuityLower Price TargetC$17.00 ➝ C$16.00
5/10/2019CIBCLower Price TargetC$30.00 ➝ C$25.00
5/10/2019CormarkLower Price TargetC$25.00 ➝ C$20.00
5/3/2019Jefferies Financial GroupLower Price TargetC$17.00 ➝ C$15.00
4/17/2019Bank of AmericaReiterated RatingUnderperformC$17.00
3/28/2019CormarkBoost Price TargetC$17.00 ➝ C$25.00
3/27/2019Canaccord GenuityDowngradeHold ➝ SellC$17.00
3/7/2019Eight CapitalDowngradeBuy ➝ NeutralC$16.00 ➝ C$24.00
3/5/2019CowenReiterated RatingMarket PerformC$29.00
2/25/2019Jefferies Financial GroupReiterated RatingUnderperformC$17.00
1/18/2019CIBCReiterated RatingOutperformC$22.00
12/10/2018CormarkBoost Price TargetC$10.00 ➝ C$17.00
12/10/2018GMP SecuritiesBoost Price TargetC$14.00 ➝ C$24.00
12/10/2018Canaccord GenuityBoost Price TargetC$9.00 ➝ C$17.00
11/15/2018Canaccord GenuityBoost Price TargetC$7.50 ➝ C$9.00
8/15/2018Canaccord GenuityUpgradeSell ➝ HoldC$6.50 ➝ C$7.50
(Data available from 6/23/2016 forward)
Cronos Group logo
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Read More

Today's Range

Now: C$10.64
Low: C$10.45
High: C$10.79

50 Day Range

MA: C$9.94
Low: C$8.69
High: C$10.95

52 Week Range

Now: C$10.64
Low: C$6.55
High: C$20.08


170,744 shs

Average Volume

790,888 shs

Market Capitalization

C$3.95 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Cronos Group?

The following Wall Street research analysts have issued stock ratings on Cronos Group in the last twelve months: Cowen Inc, Jefferies Financial Group Inc., MKM Partners, Pi Financial, Raymond James, and Stifel Nicolaus.
View the latest analyst ratings for CRON.

What is the current price target for Cronos Group?

6 Wall Street analysts have set twelve-month price targets for Cronos Group in the last year. Their average twelve-month price target is C$9.57, suggesting a possible downside of 10.1%. Raymond James has the highest price target set, predicting CRON will reach C$13.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of C$5.90 for Cronos Group in the next year.
View the latest price targets for CRON.

What is the current consensus analyst rating for Cronos Group?

Cronos Group currently has 2 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CRON will outperform the market and that investors should add to their positions of Cronos Group.
View the latest ratings for CRON.

What other companies compete with Cronos Group?

How do I contact Cronos Group's investor relations team?

The company's listed phone number is 416-504-0004. The official website for Cronos Group is www.thecronosgroup.com.